{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:22Z","timestamp":1793911282275,"version":"4.8.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Intranasal (IN) deferoxamine (DFO) has emerged over the past decade as a promising therapeutic in preclinical experiments across neurodegenerative and neurovascular diseases. As an antioxidant iron chelator, its mechanisms are multimodal, involving the binding of brain iron and the consequent engagement of several pathways to counter pathogenesis across multiple diseases. We and other research groups have shown that IN DFO rescues cognitive impairment in several rodent models of Alzheimer Disease (AD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was designed to probe dosing regimens to inform future clinical trials, while exploring mechanisms within the intracerebroventricular (ICV) streptozotocin (STZ) model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five weeks of daily IN dosing of Long Evans rats with 15\u202f\u03bcL of a 1% (0.3\u202fmg), but not 0.1% (0.03\u202fmg), solution of DFO rescued cognitive impairment caused by ICV STZ administration as assessed with the Morris Water Maze (MWM) test of spatial memory and learning. Furthermore, IN DFO modulated several aspects of the neuroinflammatory milieu of the ICV STZ model, which was assessed through a novel panel of brain cytokines and immunohistochemistry. Using RNA-sequencing and pathway analysis, STZ was shown to induce several pathways of cell death and neuroinflammation, and IN DFO engaged multiple transcriptomic pathways involved in hippocampal neuronal survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>To our knowledge this study is the first to assess the transcriptomic pathways and mechanisms associated with either the ICV STZ model or DFO treatment, and the first to demonstrate efficacy at this low dose.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2024.1528374","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T01:11:10Z","timestamp":1736730670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Jared M.","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Kosyakovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tate T.","family":"Bowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Faltesek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Stroebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan E.","family":"Abrahante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Westby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiley M.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s11064-012-0895-x","article-title":"Activation of Parp by oxidative stress induced by beta-amyloid: implications for Alzheimer's disease","volume":"37","author":"Abeti","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.1073\/pnas.0404349101","article-title":"A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism","volume":"101","author":"Atamna","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.3733","article-title":"Deferiprone in Alzheimer disease: a randomized clinical trial","author":"Ayton","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fnagi.2017.00347","article-title":"Sex differences in the cognitive and hippocampal effects of Streptozotocin in an animal model of sporadic ad","volume":"9","author":"Bao","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JAD-2010-091471","article-title":"Gm-Csf upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice","volume":"21","author":"Boyd","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11010-011-1162-1","article-title":"The hypoxic preconditioning agent deferoxamine induces poly(Adp-ribose) polymerase-1-dependent inhibition of the mitochondrial respiratory chain","volume":"363","author":"Canuelo","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of nerve growth factor to the brain via the olfactory pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J. Alzheimers Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s12640-017-9809-7","article-title":"Intranasal insulin ameliorates cerebral hypometabolism, neuronal loss, and astrogliosis in streptozotocin-induced Alzheimer's rat model","volume":"33","author":"Chen","year":"2018","journal-title":"Neurotox. Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper Mclachlan","year":"1991","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12195-019-00608-w","article-title":"Transplantation of Il-10-overexpressing bone marrow-derived mesenchymal stem cells ameliorates diabetic-induced impaired fracture healing in mice","volume":"13","author":"Cui","year":"2020","journal-title":"Cell. Mol. Bioeng."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/157016109788340721","article-title":"Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury","volume":"7","author":"Cuneo","year":"2009","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.3390\/ijms23147977","article-title":"Emerging roles of the iron chelators in inflammation","volume":"23","author":"Di Paola","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12035-019-01718-2","article-title":"Calcineurin-mediated hippocampal inflammatory alterations in streptozotocin-induced model of dementia","volume":"57","author":"Dos Santos","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-140564","article-title":"Ampk activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats","volume":"43","author":"Du","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.0c00474","article-title":"Challenges and opportunities of deferoxamine delivery for treatment of Alzheimer's disease, Parkinson's disease, and intracerebral hemorrhage","volume":"18","author":"Farr","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0006-8993(02)02981-5","article-title":"Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer's brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants","volume":"950","author":"Fawcett","year":"2002","journal-title":"Brain Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","article-title":"Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein raav Parkinson's model","author":"Febbraro","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00221-012-3101-0","article-title":"Intranasal deferoxamine improves performance in radial arm water maze, stabilizes Hif-1alpha, and phosphorylates Gsk3beta in P301L tau transgenic mice","volume":"219","author":"Fine","year":"2012","journal-title":"Exp. Brain Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2014.05.048","article-title":"Intranasally-administered deferoxamine mitigates toxicity of 6-Ohda in a rat model of Parkinsons disease","volume":"1574","author":"Fine","year":"2014","journal-title":"Brain Res."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jns.2017.07.028","article-title":"Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease","volume":"380","author":"Fine","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e01536","DOI":"10.1002\/brb3.1536","article-title":"Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement","volume":"10","author":"Fine","year":"2020","journal-title":"Brain Behav."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.neulet.2014.11.013","article-title":"Intranasal deferoxamine engages multiple pathways to decrease memory loss in the App\/Ps1 model of amyloid accumulation","volume":"584","author":"Fine","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-019-1412-9","article-title":"Neuroinflammation and fractalkine signaling in Alzheimer's disease","volume":"16","author":"Finneran","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1161\/STROKEAHA.121.037298","article-title":"Effect of Deferoxamine on trajectory of recovery after intracerebral hemorrhage: a post hoc analysis of the i-Def trial","volume":"53","author":"Foster","year":"2022","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-Ngf to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in Sars-CoV-2 pneumonia","volume":"590","author":"Grant","year":"2021","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s12035-015-9132-3","article-title":"Intracerebroventricular streptozotocin injections as a model of Alzheimer's disease: in search of a relevant mechanism","volume":"53","author":"Grieb","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic app processing in a transgenic mouse model of Alzheimer's disease","volume":"34","author":"Guo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.cell.2015.11.023","article-title":"Neuroinflammatory Tnfalpha impairs memory via astrocyte signaling","volume":"163","author":"Habbas","year":"2015","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s13346-011-0050-2","article-title":"Intranasal delivery of deferoxamine reduces spatial memory loss in App\/Ps1 mice","volume":"2","author":"Hanson","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s13346-011-0050-2","article-title":"Intranasal delivery of deferoxamine reduces spatial memory loss in App\/Ps1 mice","volume":"2","author":"Hanson","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/jpet.108.149807","article-title":"Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke","volume":"330","author":"Hanson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/biomedicines8100389","article-title":"Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions","volume":"8","author":"Jarrahi","year":"2020","journal-title":"Biomedicines"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.01.049","article-title":"Intracerebral microinjection of interleukin-4\/interleukin-13 reduces beta-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice","volume":"207","author":"Kawahara","year":"2012","journal-title":"Neuroscience"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","article-title":"Gm-Csf induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice","volume":"265","author":"Kosloski","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ph14020095","article-title":"Mechanisms of intranasal deferoxamine in neurodegenerative and neurovascular disease","volume":"14","author":"Kosyakovsky","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1021\/acschemneuro.9b00436","article-title":"Quantifying intranasally administered deferoxamine in rat brain tissue with mass spectrometry","volume":"10","author":"Kosyakovsky","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/path.1013","article-title":"Granulocyte macrophage-colony stimulating factor (Gm-Csf) recruits immune cells to the pancreas and delays Stz-induced diabetes","volume":"196","author":"Krakowski","year":"2002","journal-title":"J. Pathol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/clpt.1993.6","article-title":"A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate","volume":"53","author":"Kruck","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.4103\/0973-1296.203974","article-title":"Caffeic acid Phenethyl Ester (cape) prevents development of Stz-Icv induced dementia in rats","volume":"13","author":"Kumar","year":"2017","journal-title":"Pharmacogn. Mag."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2018.02.016","article-title":"Age-dependent effects of dimethyl fumarate on cognitive and neuropathological features in the streptozotocin-induced rat model of Alzheimer's disease","volume":"1686","author":"Majkutewicz","year":"2018","journal-title":"Brain Res."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/cancers12030739","article-title":"The multifactorial role of Parp-1 in tumor microenvironment","volume":"12","author":"Marti","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/jcb.21781","article-title":"Parp-1 modulates deferoxamine-induced Hif-1alpha accumulation through the regulation of nitric oxide and oxidative stress","volume":"104","author":"Martinez-Romero","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1002\/cpph.57","article-title":"Preclinical models of Alzheimer's disease: relevance and translational validity","volume":"84","author":"Mullane","year":"2019","journal-title":"Curr. Protoc. Pharmacol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1007\/s00415-022-11119-6","article-title":"Memaid: memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial","volume":"269","author":"Novak","year":"2022","journal-title":"J. Neurol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in Covid-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.bbi.2020.03.023","article-title":"Neuroprotective modulation of microglia effector functions following priming with interleukin 4 and 13: current limitations in understanding their mode-of-action","volume":"88","author":"Quarta","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ph15050551","article-title":"Brain glucose hypometabolism and iron accumulation in different brain regions in Alzheimer's and Parkinson's diseases","volume":"15","author":"Rao","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by Apoe genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.jcbfm.9600496","article-title":"A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (Gm-Csf)","volume":"28","author":"Schabitz","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","article-title":"Deferoxamine mesylate in patients with intracerebral haemorrhage (i-Def): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial","volume":"18","author":"Selim","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fncel.2014.00233","article-title":"Cx3cl1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity","volume":"8","author":"Sheridan","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"590789","DOI":"10.3389\/fncel.2020.590789","article-title":"The role of iron, its metabolism and ferroptosis in traumatic brain injury","volume":"14","author":"Tang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2008.03.009","article-title":"Rantes upregulation in the Alzheimer's disease brain: a possible neuroprotective role","volume":"31","author":"Tripathy","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0006-8993(97)00425-3","article-title":"Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation","volume":"764","author":"Venters","year":"1997","journal-title":"Brain Res."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"102651","DOI":"10.1016\/j.dnarep.2019.102651","article-title":"Parp-1 and its associated nucleases in DNA damage response","volume":"81","author":"Wang","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s12035-020-02138-3","article-title":"Neuroprotective effect of fractalkine on radiation-induced brain injury through promoting the M2 polarization of microglia","volume":"58","author":"Wang","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12974-020-01922-1","article-title":"Anti-inflammatory Il-10 administration rescues depression-associated learning and memory deficits in mice","volume":"17","author":"Worthen","year":"2020","journal-title":"J. Neuroinflammation"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1528374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T01:11:14Z","timestamp":1736730674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1528374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":64,"alternative-id":["10.3389\/fnins.2024.1528374"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1528374","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"article-number":"1528374"}}